GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Other Current Liabilities

PERCF (Percheron Therapeutics) Other Current Liabilities : $0.17 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Other Current Liabilities?

Percheron Therapeutics's other current liabilities for the quarter that ended in Dec. 2024 was $0.17 Mil.

Percheron Therapeutics's quarterly other current liabilities increased from Dec. 2023 ($0.15 Mil) to Jun. 2024 ($0.16 Mil) and increased from Jun. 2024 ($0.16 Mil) to Dec. 2024 ($0.17 Mil).

Percheron Therapeutics's annual other current liabilities declined from Jun. 2022 ($0.37 Mil) to Jun. 2023 ($0.13 Mil) but then increased from Jun. 2023 ($0.13 Mil) to Jun. 2024 ($0.16 Mil).

Percheron Therapeutics Other Current Liabilities Historical Data

The historical data trend for Percheron Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Other Current Liabilities Chart

Percheron Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.35 0.37 0.13 0.16

Percheron Therapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.13 0.15 0.16 0.17

Percheron Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Percheron Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Other Current Liabilities
Comparable Companies
ASX:AGH ASX:CAN ASX:RGT ASX:EOF ASX:IVX ASX:EXL ASX:ECS ASX:BP8 ASX:NXS ASX:LGP ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AWY0:Germany PER:Australia
Address
14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142
Website
https://www.percherontx.com
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.